Haverford Trust Company’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,556
| Closed | -$386K | – | 417 |
|
|
2024
Q2 | $386K | Buy |
+3,556
| New | +$419K | ﹤0.01% | 327 |
|
|
2024
Q1 | – | Sell |
-3,118
| Closed | -$379K | – | 390 |
|
|
2023
Q4 | $379K | Sell |
3,118
-90
| -3% | -$10K | ﹤0.01% | 306 |
|
|
2023
Q3 | $360K | Sell |
3,208
-250
| -7% | -$31.7K | ﹤0.01% | 295 |
|
|
2023
Q2 | $503K | Buy |
3,458
+243
| +8% | +$33K | 0.01% | 268 |
|
|
2023
Q1 | $415K | Sell |
3,215
-43
| -1% | -$5.4K | 0.01% | 283 |
|
|
2022
Q4 | $415K | Sell |
3,258
-300
| -8% | -$34.8K | 0.01% | 260 |
|
|
2022
Q3 | $372K | Sell |
3,558
-196
| -5% | -$21.5K | 0.01% | 270 |
|
|
2022
Q2 | $394K | Buy |
3,754
+100
| +3% | +$11.9K | 0.01% | 264 |
|
|
2022
Q1 | $467K | Sell |
3,654
-1,740
| -32% | -$210K | 0.01% | 262 |
|
|
2021
Q4 | $665K | Buy |
5,394
+214
| +4% | +$28K | 0.01% | 236 |
|
|
2021
Q3 | $736K | Sell |
5,180
-26
| -0.5% | -$3.83K | 0.01% | 225 |
|
|
2021
Q2 | $813K | Buy |
5,206
+427
| +9% | +$69.2K | 0.01% | 216 |
|
|
2021
Q1 | $743K | Hold |
4,779
| – | – | 0.01% | 199 |
|
|
2020
Q4 | $715K | Hold |
4,779
| – | – | 0.01% | 187 |
|
|
2020
Q3 | $632K | Sell |
4,779
-19
| -0.4% | -$2.48K | 0.01% | 183 |
|
|
2020
Q2 | $556K | Buy |
4,798
+1,852
| +63% | +$213K | 0.01% | 188 |
|
|
2020
Q1 | $289K | Buy |
2,946
+422
| +17% | +$55.3K | 0.01% | 226 |
|
|
2019
Q4 | $367K | Hold |
2,524
| – | – | 0.01% | 239 |
|
|
2019
Q3 | $336K | Hold |
2,524
| – | – | 0.01% | 242 |
|
|
2019
Q2 | $288K | Sell |
2,524
-257
| -9% | -$30.1K | 0.01% | 252 |
|
|
2019
Q1 | $345K | Sell |
2,781
-2,562
| -48% | -$291K | 0.01% | 233 |
|
|
2018
Q4 | $538K | Buy |
5,343
+397
| +8% | +$44.6K | 0.01% | 193 |
|
|
2018
Q3 | $631K | Hold |
4,946
| – | – | 0.01% | 193 |
|
|
2018
Q2 | $535K | Buy |
4,946
+2,368
| +92% | +$258K | 0.01% | 199 |
|
|
2018
Q1 | $273K | Sell |
2,578
-208
| -7% | -$24.2K | 0.01% | 255 |
|
|
2017
Q4 | $326K | Buy |
2,786
+170
| +6% | +$19.2K | 0.01% | 231 |
|
|
2017
Q3 | $297K | Buy |
2,616
+51
| +2% | +$5.89K | 0.01% | 218 |
|
|
2017
Q2 | $320K | Hold |
2,565
| – | – | 0.01% | 203 |
|
|
2017
Q1 | $304K | Buy |
2,565
+309
| +14% | +$35K | 0.01% | 218 |
|
|
2016
Q4 | $226K | Hold |
2,256
| – | – | 0.01% | 233 |
|
|
2016
Q3 | $285K | Hold |
2,256
| – | – | 0.01% | 209 |
|
|
2016
Q2 | $264K | Hold |
2,256
| – | – | 0.01% | 206 |
|
|
2016
Q1 | $234K | Hold |
2,256
| – | – | 0.01% | 216 |
|
|
2015
Q4 | $225K | Hold |
2,256
| – | – | 0.01% | 224 |
|
|
2015
Q3 | $205K | Buy |
+2,256
| New | +$226K | 0.01% | 218 |
|
|
2014
Q4 | – | Sell |
-2,069
| Closed | -$202K | – | 236 |
|
|
2014
Q3 | $202K | Buy |
+2,069
| New | +$204K | 0.01% | 221 |
|
|
2014
Q1 | – | Sell |
-2,961
| Closed | -$268K | – | 255 |
|
|
2013
Q4 | $268K | Buy |
2,961
+309
| +12% | +$26.7K | 0.01% | 229 |
|
|
2013
Q3 | $211K | Buy |
+2,652
| New | +$209K | 0.01% | 196 |
|
Other funds holding ZBH
Haverford Trust Company's ZBH Position: Q3 2024 in Review
Haverford Trust Company sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 3,556 shares — an estimated $386K sold.
Haverford Trust Company first reported a position in ZBH in Q3 2013 and held it in 38 quarters. The position peaked at $813K in Q2 2021. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.
- Haverford Trust Company reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
- Haverford Trust Company sold 3,556 Zimmer Biomet shares in Q3 2024, an estimated $386K.
- Haverford Trust Company first reported a position in Zimmer Biomet in Q3 2013 and held it in 38 quarters.
- Haverford Trust Company's Zimmer Biomet position peaked at $813K in Q2 2021.
- 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.
Based on Haverford Trust Company's 13F filing for Q3 2024, filed 5 Nov 2024.